In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 7th, 2004 | 31 | No |
19545-26-7; C15181; Wortmannin
CPD-11924; wortmanin; wortmannin
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.84 | 8.68 | -13.81 | 0 | 8 | 0 | 109 | 428.437 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.21e-01 g/l | DrugBank-experimental |
MP | 240 °C | Fluorochem |
Purity | >98% | Fluorochem |
UniProt Database Links | ACTN4_HUMAN; ENPP3_HUMAN; MYLK_HUMAN; P3C2A_HUMAN; P3C2A_MOUSE; P3C2A_PONAB; P4KA1_ARATH; P4KB1_ARATH; PI4KA_BOVIN; PI4KA_HUMAN; PI4KA_RAT; PI4KB_BOVIN; PI4KB_CALJA; PI4KB_CALMO; PI4KB_HUMAN; PI4KB_MOUSE; PI4KB_OTOGA; PI4KB_PAPAN; PI4KB_RAT; PI4KB_RHIFE | ChEBI |
Target | PI3K | Selleck Chemicals |
Reactome Database Links | REACT_147854 | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MTOR-2-E | Serine/threonine-protein Kinase MTOR (cluster #2 Of 3), Eukaryotic | Eukaryotes | 40 | 0.33 | Binding ≤ 10μM |
MYLK-1-E | Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.24 | Binding ≤ 10μM |
P85A-2-E | PI3-kinase P85-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1 | 0.41 | Binding ≤ 10μM |
P85B-2-E | PI3-kinase P85-beta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5 | 0.37 | Binding ≤ 10μM |
PK3CA-2-E | PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5 | 0.37 | Binding ≤ 10μM |
PK3CB-2-E | PI3-kinase P110-beta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5 | 0.37 | Binding ≤ 10μM |
PK3CD-2-E | PI3-kinase P110-delta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 9 | 0.36 | Binding ≤ 10μM |
PK3CG-3-E | PI3-kinase P110-gamma Subunit (cluster #3 Of 3), Eukaryotic | Eukaryotes | 89 | 0.32 | Binding ≤ 10μM |
PLK1-1-E | Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.37 | Binding ≤ 10μM |
PLK3-1-E | Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 49 | 0.33 | Binding ≤ 10μM |
PRKDC-1-E | DNA-dependent Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.31 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 10000 | 0.23 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 98 | 0.32 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PRKDC_HUMAN | P78527 | DNA-dependent Protein Kinase, Human | 120 | 0.31 | Binding ≤ 1μM |
MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 40 | 0.33 | Binding ≤ 1μM |
MYLK_CHICK | P11799 | Myosin Light Chain Kinase, Smooth Muscle, Chick | 260 | 0.30 | Binding ≤ 1μM |
MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 170 | 0.31 | Binding ≤ 1μM |
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 1 | 0.41 | Binding ≤ 1μM |
PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 10 | 0.36 | Binding ≤ 1μM |
PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 4 | 0.38 | Binding ≤ 1μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 19 | 0.35 | Binding ≤ 1μM |
P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 1.2 | 0.40 | Binding ≤ 1μM |
P85B_HUMAN | O00459 | PI3-kinase P85-beta Subunit, Human | 4.2 | 0.38 | Binding ≤ 1μM |
PLK1_HUMAN | P53350 | Serine/threonine-protein Kinase PLK1, Human | 5.8 | 0.37 | Binding ≤ 1μM |
PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 220 | 0.30 | Binding ≤ 1μM |
PRKDC_HUMAN | P78527 | DNA-dependent Protein Kinase, Human | 120 | 0.31 | Binding ≤ 10μM |
MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 40 | 0.33 | Binding ≤ 10μM |
MYLK_CHICK | P11799 | Myosin Light Chain Kinase, Smooth Muscle, Chick | 260 | 0.30 | Binding ≤ 10μM |
MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 170 | 0.31 | Binding ≤ 10μM |
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 1 | 0.41 | Binding ≤ 10μM |
PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 10 | 0.36 | Binding ≤ 10μM |
PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 4 | 0.38 | Binding ≤ 10μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 19 | 0.35 | Binding ≤ 10μM |
P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 1.2 | 0.40 | Binding ≤ 10μM |
P85B_HUMAN | O00459 | PI3-kinase P85-beta Subunit, Human | 4.2 | 0.38 | Binding ≤ 10μM |
PLK1_HUMAN | P53350 | Serine/threonine-protein Kinase PLK1, Human | 1300 | 0.27 | Binding ≤ 10μM |
PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 220 | 0.30 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.23 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 98 | 0.32 | Functional ≤ 10μM |
Description | Species |
---|---|
Constitutive PI3K/AKT Signaling in Cancer |
Description | Species |
---|---|
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
CD28 dependent PI3K/Akt signaling | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
Costimulation by the CD28 family | |
Cyclin A/B1 associated events during G2/M transition | |
Cytosolic sensors of pathogen-associated DNA | |
DAP12 signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
G alpha (12/13) signalling events | |
G alpha (q) signalling events | |
G beta:gamma signalling through PI3Kgamma | |
GAB1 signalosome | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
HSF1-dependent transactivation | |
Interleukin receptor SHC signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-7 signaling | |
IRF3-mediated induction of type I IFN | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
Mitotic Metaphase/Anaphase Transition | |
Mitotic Prometaphase | |
Mitotic Telophase/Cytokinesis | |
mTOR signalling | |
Nephrin interactions | |
Nonhomologous End-joining (NHEJ) | |
Phosphorylation of Emi1 | |
Phosphorylation of the APC/C | |
PI-3K cascade | |
PI3K Cascade | |
PI3K events in ERBB2 signaling | |
PI3K events in ERBB4 signaling | |
PI3K/AKT activation | |
PIP3 activates AKT signaling | |
Polo-like kinase mediated events | |
Processing of DNA ends prior to end rejoining | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Release of eIF4E | |
Resolution of Sister Chromatid Cohesion | |
Rho GTPase cycle | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Role of phospholipids in phagocytosis | |
S6K1-mediated signalling | |
Separation of Sister Chromatids | |
Signaling by constitutively active EGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR1 fusion mutants | |
Signaling by SCF-KIT | |
Smooth Muscle Contraction | |
Synthesis of PIPs at the plasma membrane | |
Tie2 Signaling | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated vascular permeability |